More info on CinGx and are marketing partner
Allegiance Completes Private Placement
August 27, 2012 -- The TSX has given final approval to the purchase by Palm American Investment Inc. of 700,000 common shares and 700,000 share purchase warrants of Allegiance Equity Corporation (TSXV:ANQ) at $0.20 per share. The share purchase warrants are each exercisable into one common share at $0.40 up to and until March 31,2013 and thereafter at a price of $0.75 up till and until June 30,2014 at which time the warrants expire.
Purpose of Financing
The funding will be used for the following purposes
-To capitalize on new opportunities for CinGx and Relieva our two proprietary technologies
-To meet ongoing administrative and operational expenses.
ABOUT ALLEGIANCE EQUITY CORPORATION
CING-X and Relieva(TM) our two core technologies enhance the value of foods and dermatology products providing mass market products with distinct competitive advantages. Allegiance targets markets having clearly identified product deficiencies and dissatisfied consumers afflicted with common diseases and conditions including Alzheimer's, dementia, diabetes and inflammatory skin conditions, Allegiance obtained regulatory approvals and patents for these unique compounds and formulations for licensing and royalty revenues.
RECENT DEVELOPMENTS AND UPDATE
CinGx has received interest from two large multinationals and a Canadian tea manufacturer in the beverage industry
Samples of CinGx are being evaluated and tested by three different companies for
-the bottled beverage industry as an additive for energy and wellness beverages
-use as an additive for cartridges used in coffee and tea brewers
-uses an infusion for tea bags
In addition Nealanders International Inc recently launched its sales efforts upon approval of its Master Ingredient File for CinGx to its 2,500 clients. Nealanders reports a high level of interest and requests foe samples and further information
Acceptance of Master Ingredient File for CING-X expedites Regulatory process increasing appeal to the multinationals and facilitates mass market commercialization of CING-X.
Nealanders International Inc. (Nealanders) has been granted a product license NPN 80032734 for Apple Flavored CING-X, based on review of the Ingredient Master File for CING-X filed with the Natural Health Products Directorate (NHPD) in 2011.
Apple flavored CING-X a pleasant tasting beverage that comes in a convenient 10 gram single serve crystal drink format, provides the following Health Benefits-Helps to promote healthy blood glucose levels and improved brain function enhancing mental and physical capacity and performance.
Interest of Management Notice of Intention to Distribute
Palm American Investment Inc. holds 2,350,997 common shares and 700,000 common share purchase warrants of Allegiance and is controlled by David Solomon, Marilyn Bloovol and members of their family. Palm American Investment Inc. filed a Notice of Intention to sell up to 200,000 common shares on August 27, 2012, by way of private sale or on the market from time to time. There are presently 8,341,087 common shares and 700,000 share purchase warrants of Allegiance issued and outstanding.
Additional information relevant to the Company's activities, including the Company's press releases can found on SEDAR at www.sedar.com
The TSX Venture Exchange has not reviewed and does not accept responsibility FOR THE ADEQUACY OR ACCURACY FOR HIS PRESS RELEASE, WHICH HAS BEEN PREPARED BY MANAGEMENT.
For further information please contact:
Allegiance Equity Corporation: David Solomon, President & CEO Tel: 416-630-1221
Davidsolomon@allegianceequity.com
Allegiance Completes Private Placement
August 27, 2012 -- The TSX has given final approval to the purchase by Palm American Investment Inc. of 700,000 common shares and 700,000 share purchase warrants of Allegiance Equity Corporation (TSXV:ANQ) at $0.20 per share. The share purchase warrants are each exercisable into one common share at $0.40 up to and until March 31,2013 and thereafter at a price of $0.75 up till and until June 30,2014 at which time the warrants expire.
Purpose of Financing
The funding will be used for the following purposes
-To capitalize on new opportunities for CinGx and Relieva our two proprietary technologies
-To meet ongoing administrative and operational expenses.
ABOUT ALLEGIANCE EQUITY CORPORATION
CING-X and Relieva(TM) our two core technologies enhance the value of foods and dermatology products providing mass market products with distinct competitive advantages. Allegiance targets markets having clearly identified product deficiencies and dissatisfied consumers afflicted with common diseases and conditions including Alzheimer's, dementia, diabetes and inflammatory skin conditions, Allegiance obtained regulatory approvals and patents for these unique compounds and formulations for licensing and royalty revenues.
RECENT DEVELOPMENTS AND UPDATE
CinGx has received interest from two large multinationals and a Canadian tea manufacturer in the beverage industry
Samples of CinGx are being evaluated and tested by three different companies for
-the bottled beverage industry as an additive for energy and wellness beverages
-use as an additive for cartridges used in coffee and tea brewers
-uses an infusion for tea bags
In addition Nealanders International Inc recently launched its sales efforts upon approval of its Master Ingredient File for CinGx to its 2,500 clients. Nealanders reports a high level of interest and requests foe samples and further information
Acceptance of Master Ingredient File for CING-X expedites Regulatory process increasing appeal to the multinationals and facilitates mass market commercialization of CING-X.
Nealanders International Inc. (Nealanders) has been granted a product license NPN 80032734 for Apple Flavored CING-X, based on review of the Ingredient Master File for CING-X filed with the Natural Health Products Directorate (NHPD) in 2011.
Apple flavored CING-X a pleasant tasting beverage that comes in a convenient 10 gram single serve crystal drink format, provides the following Health Benefits-Helps to promote healthy blood glucose levels and improved brain function enhancing mental and physical capacity and performance.
Interest of Management Notice of Intention to Distribute
Palm American Investment Inc. holds 2,350,997 common shares and 700,000 common share purchase warrants of Allegiance and is controlled by David Solomon, Marilyn Bloovol and members of their family. Palm American Investment Inc. filed a Notice of Intention to sell up to 200,000 common shares on August 27, 2012, by way of private sale or on the market from time to time. There are presently 8,341,087 common shares and 700,000 share purchase warrants of Allegiance issued and outstanding.
Additional information relevant to the Company's activities, including the Company's press releases can found on SEDAR at www.sedar.com
The TSX Venture Exchange has not reviewed and does not accept responsibility FOR THE ADEQUACY OR ACCURACY FOR HIS PRESS RELEASE, WHICH HAS BEEN PREPARED BY MANAGEMENT.
For further information please contact:
Allegiance Equity Corporation: David Solomon, President & CEO Tel: 416-630-1221
Davidsolomon@allegianceequity.com
